ProAssurance Corporation (PRA) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    ProAssurance Corporation

    NYSE: PRA · Real-Time Price · USD
    23.77
    0.02 (0.08%)
    At close: Sep 04, 2025, 3:59 PM
    23.76
    -0.04%
    After-hours: Sep 04, 2025, 04:04 PM EDT

    ProAssurance Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 1.13B 1.14B 1.1B 1.12B
    Cost of Revenue
    		 874.87M 935.31M 909.94M 862.85M
    Gross Profit
    		 253.34M 1.14B 1.1B 1.08B
    Operating Income
    		 89.86M 34.34M 28.03M 166.33M
    Interest Income
    		 n/a n/a n/a n/a
    Pretax Income
    		 63.08M -39.15M -6.22M 146.61M
    Net Income
    		 52.74M -38.6M -402K 144.12M
    Selling & General & Admin
    		 183.59M -39.15M n/a n/a
    Research & Development
    		 n/a n/a n/a n/a
    Other Expenses
    		 6.67M 205.38M 1.11B 928.83M
    Operating Expenses
    		 190.26M 166.23M 1.11B 928.83M
    Interest Expense
    		 22.34M 23.15M 20.37M 19.72M
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 1.07B 1.1B 1.11B 994.04M
    Income Tax Expense
    		 10.33M -545K -5.81M 2.48M
    Shares Outstanding (Basic)
    		 51.1M 52.64M 54.01M 53.96M
    Shares Outstanding (Diluted)
    		 51.27M 52.79M 54.14M 54.06M
    EPS (Basic)
    		 1.03 -0.73 -0.01 2.67
    EPS (Diluted)
    		 1.03 -0.73 -0.01 2.67
    EBITDA
    		 103.17M 10.02M 52.22M 203.89M
    EBIT
    		 92.15M -16M 14.16M 166.33M
    Depreciation & Amortization
    		 17.75M 26.02M 38.06M 37.25M

    Add to Watchlist